Viewing Study NCT00252850


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2026-01-07 @ 11:22 AM
Study NCT ID: NCT00252850
Status: COMPLETED
Last Update Posted: 2022-11-10
First Post: 2005-11-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
Sponsor: Sangamo Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module